2 hours ago
1
JHVEPhoto/iStock Editorial via Getty Images
A class action lawsuit has been filed against CVS Caremark (NYSE:CVS), the pharmacy benefit manager for health insurer Aetna, after it dropped Eli Lilly's (NYSE:LLY) weight loss med Zepbound (tirzepatide) from its covered formulary list and replaced it with
English (US) ·